======= FABP1 ======= == Gene Information == * **Official Symbol**: FABP1 * **Official Name**: fatty acid binding protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2168|2168]] * **UniProt**: [[https://www.uniprot.org/uniprot/P07148|P07148]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FABP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FABP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/134650|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Plays a role in lipoprotein-mediated cholesterol uptake in hepatocytes (PubMed:25732850). Binds cholesterol (PubMed:25732850). Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport (By similarity). {ECO:0000250|UniProtKB:P82289, ECO:0000269|PubMed:25732850}. |Lipocalin| |apical cortex| |bile acid binding| |positive regulation of fatty acid beta-oxidation| |long-chain fatty acid transporter activity| |positive regulation of fatty acid oxidation| |regulation of fatty acid beta-oxidation| |antioxidant activity| |fatty acid binding| |positive regulation of lipid catabolic process| |triglyceride catabolic process| |regulation of fatty acid oxidation| |intestinal absorption| |positive regulation of fatty acid metabolic process| |neutral lipid catabolic process| |acylglycerol catabolic process| |peroxisomal matrix| |glycerolipid catabolic process| |regulation of lipid catabolic process| |drug binding| |long-chain fatty acid transport| |cellular response to hydrogen peroxide| |fatty acid transport| |digestive system process| |triglyceride metabolic process| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |regulation of fatty acid metabolic process| |cellular oxidant detoxification| |negative regulation of cysteine-type endopeptidase activity| |acylglycerol metabolic process| |neutral lipid metabolic process| |cellular detoxification| |phospholipid binding| |digestion| |cellular response to antibiotic| |response to hydrogen peroxide| |detoxification| |cellular response to reactive oxygen species| |monocarboxylic acid transport| |positive regulation of small molecule metabolic process| |positive regulation of lipid metabolic process| |regulation of cellular ketone metabolic process| |cellular response to hypoxia| |response to reactive oxygen species| |cellular lipid catabolic process| |cellular response to decreased oxygen levels| |cellular response to toxic substance| |cellular response to oxygen levels| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |cellular response to oxidative stress| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |negative regulation of peptidase activity| |organic acid transport| |carboxylic acid transport| |lipid transport| |lipid catabolic process| |response to antibiotic| |lipid localization| |response to hypoxia| |negative regulation of proteolysis| |response to decreased oxygen levels| |positive regulation of cellular catabolic process| |glycerolipid metabolic process| |response to oxygen levels| |response to oxidative stress| |chromatin binding| |regulation of lipid metabolic process| |cellular response to drug| |regulation of endopeptidase activity| |regulation of small molecule metabolic process| |positive regulation of catabolic process| |regulation of peptidase activity| |negative regulation of hydrolase activity| |organic anion transport| |response to toxic substance| |response to inorganic substance| |anion transport| |protein-containing complex| |regulation of proteolysis| |positive regulation of hydrolase activity| |negative regulation of catalytic activity| |regulation of cellular catabolic process| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |cellular lipid metabolic process| |regulation of catabolic process| |negative regulation of cell death| |response to drug| |negative regulation of cellular protein metabolic process| |cellular response to oxygen-containing compound| |negative regulation of protein metabolic process| |negative regulation of molecular function| |response to abiotic stimulus| |lipid metabolic process| |regulation of hydrolase activity| |ion transport| |positive regulation of catalytic activity| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of cell death| |cellular response to stress| |organic substance catabolic process| |positive regulation of molecular function| |cellular catabolic process| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.71| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.8| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|1.83| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.02| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|2.7| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13446 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}